Anjali Zarkar

4.2k total citations
26 papers, 319 citations indexed

About

Anjali Zarkar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anjali Zarkar has authored 26 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Anjali Zarkar's work include Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Advanced Radiotherapy Techniques (5 papers). Anjali Zarkar is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Advanced Radiotherapy Techniques (5 papers). Anjali Zarkar collaborates with scholars based in United Kingdom, India and Canada. Anjali Zarkar's co-authors include Nicholas D. James, J. Glaholm, Syed A. Hussain, Deborah Stocken, D. Peake, D. M. A. WALLACE, Christopher Scrase, Vincent Khoo, Isabel Syndikus and David P. Dearnaley and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Anjali Zarkar

26 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anjali Zarkar United Kingdom 9 202 100 87 66 64 26 319
Marketa Skala Australia 13 278 1.4× 158 1.6× 62 0.7× 96 1.5× 54 0.8× 23 392
E. Martinez Spain 9 242 1.2× 86 0.9× 83 1.0× 26 0.4× 72 1.1× 20 332
Nasiruddin Mohammed United States 7 229 1.1× 129 1.3× 47 0.5× 104 1.6× 45 0.7× 15 303
Nirdosh Kumar Gogna Australia 11 297 1.5× 116 1.2× 112 1.3× 99 1.5× 104 1.6× 13 430
Joseph P. Rodgers United States 10 163 0.8× 69 0.7× 118 1.4× 30 0.5× 53 0.8× 30 338
Emile N. van Lin Netherlands 10 360 1.8× 219 2.2× 71 0.8× 173 2.6× 59 0.9× 11 487
Srinath Kotamarti United States 9 160 0.8× 37 0.4× 80 0.9× 22 0.3× 51 0.8× 33 262
Wesley W. Choi United States 8 299 1.5× 70 0.7× 91 1.0× 59 0.9× 71 1.1× 11 435
Kris Wallace Canada 7 230 1.1× 66 0.7× 70 0.8× 25 0.4× 43 0.7× 10 300
Carol Fraser‐Browne New Zealand 8 321 1.6× 118 1.2× 56 0.6× 50 0.8× 38 0.6× 13 380

Countries citing papers authored by Anjali Zarkar

Since Specialization
Citations

This map shows the geographic impact of Anjali Zarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjali Zarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjali Zarkar more than expected).

Fields of papers citing papers by Anjali Zarkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjali Zarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjali Zarkar. The network helps show where Anjali Zarkar may publish in the future.

Co-authorship network of co-authors of Anjali Zarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Anjali Zarkar. A scholar is included among the top collaborators of Anjali Zarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjali Zarkar. Anjali Zarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarkar, Anjali, et al.. (2023). First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer. SHILAP Revista de lepidopterología. 4(4). 464–472. 4 indexed citations
2.
Zarkar, Anjali, Sarah Pirrie, Clive Stubbs, et al.. (2022). A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial. Clinical Genitourinary Cancer. 20(5). 473–481. 2 indexed citations
3.
James, Nicholas D., Ann Pope, Amisha Desai, et al.. (2022). Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer. SHILAP Revista de lepidopterología. 3(6). 484–493. 3 indexed citations
4.
Gordon, Naheema S., Laura Baxter, Anshita Goel, et al.. (2021). Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study. British Journal of Urology. 129(1). 32–34. 3 indexed citations
5.
James, Nicholas D., Sarah Pirrie, Wenyu Liu, et al.. (2020). A phase I/II feasibility study of cetuximab with 5FU and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer.. Journal of Clinical Oncology. 38(6_suppl). 491–491. 2 indexed citations
6.
Grunfeld, Elizabeth A., et al.. (2019). Feasibility randomised controlled trial of a guided workbook intervention to support work-related goals among cancer survivors in the UK. BMJ Open. 9(1). e022746–e022746. 13 indexed citations
7.
Parker, Chris, Noel W. Clarke, Adrian Cook, et al.. (2019). Timing of radiotherapy (RT) after radical prostatectomy (RP): First results from the RADICALS RT randomised controlled trial (RCT) [NCT00541047]. Annals of Oncology. 30. v883–v884. 36 indexed citations
8.
Dearnaley, David P., Clare Griffin, Rebecca Lewis, et al.. (2018). Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL). International Journal of Radiation Oncology*Biology*Physics. 103(3). 605–617. 43 indexed citations
9.
Glynn, Patricia, et al.. (2017). Interstitial lung disease secondary to Cetuximab in bladder cancer: an Oncologist’s perspective. BMJ Case Reports. 2017. bcr–2017. 1 indexed citations
10.
Sadhra, Steven, et al.. (2017). Usefulness and engagement with a guided workbook intervention (WorkPlan) to support work related goals among cancer survivors. BMC Psychology. 5(1). 34–34. 10 indexed citations
11.
Stevens, Andrew, et al.. (2017). Treatment outcomes using involved field and involved site radiotherapy for NHL and HL: Retrospective analysis from a large UK Radiotherapy centre. Hematological Oncology. 35(S2). 333–333. 1 indexed citations
12.
13.
Afshar, Mehran, M E Foster, Emilio Porfiri, et al.. (2016). The PD-1/PD-L1 Axis in the Pathogenesis of Urothelial Bladder Cancer and Evaluating its Potential as a Therapeutic Target. Future Oncology. 12(5). 595–600. 9 indexed citations
14.
Staffurth, John, Olivia Naismith, S. Gulliford, et al.. (2015). Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 92(4). 874–883. 77 indexed citations
15.
Zarkar, Anjali, et al.. (2014). EP-1773: Evaluating the use of bladder volume measurement ultrasound device in radiotherapy. Radiotherapy and Oncology. 111. S277–S278. 1 indexed citations
16.
Stevenson, Robert B., Daniel Ford, J. Glaholm, et al.. (2014). The sequential use of abiraterone and enzalutamide in metastatic castrate resistant prostate cancer patients: Experience from seven U.K. centers.. Journal of Clinical Oncology. 32(4_suppl). 125–125. 11 indexed citations
17.
18.
Sherriff, Jenny, Agustín Martín-Clavijo, Peter Nightingale, & Anjali Zarkar. (2012). Adjuvant nodal radiation therapy for malignant melanoma with single region nodal metastasis. Journal of Radiation Oncology. 1(4). 373–380. 1 indexed citations
19.
Hussain, Syed A., Deborah Stocken, D. Peake, et al.. (2004). Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer. British Journal of Cancer. 90(11). 2106–2111. 52 indexed citations
20.
Hussain, Syed A., Deborah Stocken, D. Peake, et al.. (2004). Long-term results of a phase II study of synchronous chemo radiotherapy in muscle invasive bladder cancer. Journal of Clinical Oncology. 22(14_suppl). 4585–4585. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marketa Skala Breakdown of academic impact, for papers by E. Martinez Breakdown of academic impact, for papers by Nasiruddin Mohammed Breakdown of academic impact, for papers by Nirdosh Kumar Gogna Breakdown of academic impact, for papers by Joseph P. Rodgers Breakdown of academic impact, for papers by Emile N. van Lin Breakdown of academic impact, for papers by Srinath Kotamarti Breakdown of academic impact, for papers by Wesley W. Choi Breakdown of academic impact, for papers by Kris Wallace Breakdown of academic impact, for papers by Carol Fraser‐Browne
Rankless by CCL
2026